Intangible Asset Valuation Under Ind AS 38: A Comprehensive Guide for Boards Before Approval
Intangible assets now routinely make up the largest single line item on the balance sheet of technology-led, brand-driven, and platform businesses, ahead of property, plant, and equipment, and often ahead of goodwill itself. Yet intangible asset valuation under Ind AS 38 frequently receives less board scrutiny than a comparable tangible asset purchase, largely because directors treat the underlying accounting standard as a technical accounting matter rather than a judgment-heavy valuation exercise with direct consequences for reported earnings, debt covenants, and eventually, IPO readiness.
Ind AS 38 (Intangible Assets) governs recognition and measurement, but it does not by itself resolve the valuation question. Once an intangible asset clears the recognition threshold set out in (https://www.icai.org/post/release-educational-material-indas38) someone still has to determine what it is actually worth and that determination sits squarely in the domain of judgment, assumptions, and methodology that a board is expected to interrogate before sign-off.
Why Intangible Asset Valuation Under Ind AS 38 Demands Board-Level Attention
Three separate triggers bring Ind AS 38 valuations to the boardroom, and each carries a distinct standard of scrutiny:
Business Combinations (Ind AS 103): Every acquisition requires identifiable intangible assets, customer relationships, technology, trademarks, non-compete agreements to be recognized separately from goodwill at fair value as part of Purchase Price Allocation (PPA). Internally Generated Intangibles: Development costs that meet the six-point recognition criteria under paragraph 57 of Ind AS 38 must be capitalized, requiring the board to approve both the technical feasibility judgment and the resulting valuation.
Impairment Testing (linked to Ind AS 36): Indefinite-life intangibles and goodwill require annual impairment testing, and finite-life intangibles require testing whenever indicators of impairment exist placing a recurring valuation obligation on the board’s audit committee.
The Recognition Threshold: Getting the Foundation Right Before Valuation Begins
A valuation is only as sound as the recognition judgment underneath it. Ind AS 38 requires an intangible asset to satisfy three cumulative conditions before it can even be measured:
1. Identifiability: The asset must be separable (capable of being sold, transferred, or licensed independently) or must arise from contractual or legal rights, regardless of separability.
2. Control: The entity must have the power to obtain future economic benefits from the asset and restrict others’ access to those benefits typically evidenced by legal rights, though not exclusively.
3. Future Economic Benefits: The asset must be expected to generate probable future economic benefit, whether through revenue, cost savings, or other quantifiable value.
The most common board-level error I encounter is treating internally generated intangibles casually at the recognition stage. Ind AS 38 draws a hard line between the ‘research phase’ and the ‘development phase’. Research expenditure must be expensed as incurred with no exceptions. Development expenditure can only be capitalized once the entity demonstrates, cumulatively, technical feasibility, intention to complete, ability to use or sell the asset, probable future economic benefit, availability of resources, and the ability to reliably measure the expenditure. Boards approving capitalization of development spend should ask management to walk through each of these six criteria individually and not as a bundled assertion.
Valuation Methodologies: The Technical Mechanics
Once an intangible asset clears recognition, three valuation approaches are generally applied, each suited to different asset types and data availability:
1. The Relief-from-Royalty Method
Used predominantly for trademarks, brand names, and licensed technology, this method values the asset based on the royalty the owner is relieved from paying a third party by owning rather than licensing the asset.
For example, a company owns a trademark generating INR 500 million in annual revenue. Comparable licensing arrangements in the sector command a 3% royalty rate. The pre-tax royalty saving is INR 15 million annually. Projected over the trademark’s useful life and discounted at an appropriate rate reflecting the asset’s risk profile, the present value of these savings is net of the tax amortization benefit where applicable which constitutes the trademark’s fair value.
The critical judgment inputs are the royalty rate (typically benchmarked against comparable licensing databases or transactions) and the projected revenue base, both of which a board should expect management and the valuer to defend with external evidence rather than internal assumption alone.
2. The Multi-Period Excess Earnings Method (MPEEM)
MPEEM is the standard approach for the primary intangible asset in an acquisition is most often customer relationships or core technology. It isolates the cash flows attributable specifically to that asset by deducting “contributory asset charges” for all other assets (working capital, fixed assets, workforce, other intangibles) that also contribute to generating the overall business’s cash flows.
The formula in its simplified form is expressed as:
Excess Earnings = Total Projected Cash Flows − Contributory Asset Charges
The resulting excess earnings stream is then discounted at a rate specific to the risk profile of that asset typically higher than the overall business’s WACC, since a single customer relationship or technology asset carries more risk than the diversified business as a whole.
Because MPEEM can only be applied to one primary asset in a PPA exercise (to avoid double-counting), boards should confirm that the valuer has correctly identified which intangible is genuinely “primary” before the methodology is applied.
3. The With-and-Without Method (WWM)
WWM is typically used for non-compete agreements and other intangibles where the value lies in the incremental cash flow protection the asset provides. The business is valued twice once assuming the asset exists (protecting the company from competitive erosion) and once assuming it does not and the difference between the two scenarios represents the asset’s value.
This method is inherently sensitive to the probability and severity assumptions used for the “without” scenario, which is precisely where board-level challenge adds the most value, an aggressive assumption about competitive erosion in the absence of the asset can materially inflate the resulting valuation.
Useful Life and Amortization: A Judgment Boards Must Not Rubber-Stamp
Ind AS 38 requires an entity to assess whether an intangible asset’s useful life is finite or indefinite. Indefinite does not mean infinite, it means no foreseeable limit to the period over which the asset is expected to generate cash flows. This is a high bar, and indefinite-life classifications (common for certain trademarks) shift the asset out of routine amortization and into the annual impairment testing regime under Ind AS 36 instead.
For finite-life intangibles, the amortization method should reflect the pattern in which the asset’s economic benefits are consumed, straight-line method is common but not automatically correct, particularly for customer relationship assets where attrition curves are rarely linear. Boards should ask whether the amortization pattern was tested against actual usage or consumption data rather than defaulted to straight-line for administrative convenience.
A Board’s Pre-Approval Checklist
Before approving an intangible asset valuation whether arising from an acquisition, an internal capitalization decision, or an annual impairment review, directors should work through the following:
Recognition Test: Has management demonstrated all three recognition criteria (identifiability, control, future economic benefit) independently, rather than as a bundled conclusion?
Research vs. Development Split: For internally generated intangibles, is there documented evidence supporting each of the six development-phase capitalization criteria mentioned under paragraph 57.
Methodology Fit: Does the valuation method (Relief-from-Royalty, MPEEM, or WWM) match the nature of the specific asset being valued, rather than being applied by default.
Discount Rate Calibration: Is the discount rate applied to the asset-specific cash flows differentiated from the overall business WACC, reflecting the asset’s distinct risk profile.
Contributory Asset Charges: For MPEEM valuations, have contributory asset charges been applied for all supporting assets to avoid overstating the primary intangible’s value?
Useful Life Classification: Is the finite vs. indefinite useful life determination supported by a documented analysis, and not simply carried forward from the prior period?
PPA Consistency: For acquisition-related intangibles, has the valuation been cross-checked against the overall purchase price allocation to confirm the residual goodwill figure is reasonable?
Intangible asset valuation under Ind AS 38 sits at the intersection of accounting judgment and financial valuation discipline. A board that engages with the recognition criteria, interrogates the methodology, and tests the underlying assumptions converts what could be a routine sign-off into a genuinely defensible position, the one that holds up under statutory audit, and later, under IPO due diligence.
Need a defensible intangible asset valuation for an acquisition, capitalization decision, or impairment review?
Connect with the team at Omnifin at ‘valuation@omnifinsolutions.com’ for a comprehensive assessment.
Disclaimer: This article is intended for general informational guidance only and does not constitute formal valuation, accounting, or legal advice. Positions under Ind AS should be evaluated against the specific facts, disclosures, and professional judgment applicable at the time of preparation.